NCT05850559View on ClinicalTrials.gov

Assessment of the Diagnostic Role of Serum Insulin-like Growth Factor Binding Protein-3 as a Potential Biomarker for Colorectal Cancer (CRC) in Egypt

Not yet recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

October 5, 2023

Primary Completion Date

October 1, 2025

Study Completion Date

October 1, 2026

Conditions
Colorectal Cancer
Interventions
DIAGNOSTIC_TEST

evaluation of diagnostic importance of insulin like growth factor binding protein3 in patient with recently diagnosed as Colorectal cancer

evaluation of diagnostic importance of insulin like growth factor binding protein3 in patient with recently diagnosed as Colorectal cancer by Enzyme-linked immunosorbent assay (ELISA

All Listed Sponsors
lead

Assiut University

OTHER

NCT05850559 - Assessment of the Diagnostic Role of Serum Insulin-like Growth Factor Binding Protein-3 as a Potential Biomarker for Colorectal Cancer (CRC) in Egypt | Biotech Hunter | Biotech Hunter